ADA Partners with DEA on Opioid Epidemic Webinar
The ADA and DEA are offering a three-part webinar series on the proper handling of controlled substances to combat the opioid epidemic.
The ADA and DEA are offering a three-part webinar series on the proper handling of controlled substances to combat the opioid epidemic.
As consolidation accelerates, the "Invisible DSO" model is gaining traction. Chip Fichtner explains how to secure back-office support and capital while retaining clinical autonomy—and how to avoid leaving millions on the table.